CLOV Clover Health Investments Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: CLOV

Price (delayed)

$3.98

Market cap

$2.1B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.12

Enterprise value

$1.92B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 13

Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral ...

Highlights
The revenue has grown by 49% YoY and by 15% from the previous quarter
The gross profit has grown by 14% since the previous quarter and by 3.7% year-on-year
CLOV's EPS has dropped by 140% year-on-year but it is up by 29% since the previous quarter
The net income has dropped by 127% year-on-year but it rose by 33% since the previous quarter
Clover Health Investments's gross margin has decreased by 30% YoY
Clover Health Investments's quick ratio has decreased by 20% QoQ and by 17% YoY
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.cloverhealth.com
Peers: PHR PHUN

Key stats

What are the main financial stats of CLOV

CLOV stock price

How has the Clover Health Investments stock price performed over time
Intraday
9.04%
1 week
-4.78%
1 month
50.19%
1 year
29.22%
YTD
69.36%
QTD
126.14%

Financial performance

How have Clover Health Investments's revenue and profit performed over time
Revenue
$2.21B
Gross profit
$406.55M
Operating income
-$56.92M
Net income
-$56.94M
Gross margin
18.4%
Net margin
-2.6%
The operating income has plunged by 134% YoY but it has grown by 33% from the previous quarter
The net income has dropped by 127% year-on-year but it rose by 33% since the previous quarter
Clover Health Investments's operating margin has plunged by 63% YoY but it has increased by 41% from the previous quarter
The net margin has plunged by 53% YoY but it has grown by 41% from the previous quarter

Price vs fundamentals

How does CLOV's price correlate with its fundamentals

Growth

What is Clover Health Investments's growth rate over time

Valuation

What is Clover Health Investments stock price valuation
P/E
N/A
P/B
6.15
P/S
0.94
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.87
CLOV's EPS has dropped by 140% year-on-year but it is up by 29% since the previous quarter
The P/B is 48% above the 5-year quarterly average of 3.8 and 48% above the last 4 quarters average of 3.8
The equity has grown by 10% from the previous quarter
The P/S is 63% below the 5-year quarterly average of 2.3 but 23% above the last 4 quarters average of 0.7
The revenue has grown by 49% YoY and by 15% from the previous quarter

Efficiency

How efficient is Clover Health Investments business performance
The ROA has plunged by 140% YoY but it has grown by 36% from the previous quarter
CLOV's ROE has plunged by 128% YoY but it is up by 33% from the previous quarter
The return on invested capital has dropped by 61% year-on-year but it is up by 31% since the previous quarter
CLOV's return on sales has dropped by 53% year-on-year but it is up by 41% since the previous quarter

Dividends

What is CLOV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CLOV.

Financial health

How did Clover Health Investments financials performed over time
CLOV's total assets is 95% greater than its total liabilities
Clover Health Investments's total liabilities has soared by 54% from the previous quarter and by 45% YoY
CLOV's total assets is up by 29% since the previous quarter and by 20% year-on-year
The debt is 100% less than the equity
The equity has grown by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.